EP2391420A1 - Système pour moduler une perfusion dans la microcirculation sanguine - Google Patents
Système pour moduler une perfusion dans la microcirculation sanguineInfo
- Publication number
- EP2391420A1 EP2391420A1 EP10701028A EP10701028A EP2391420A1 EP 2391420 A1 EP2391420 A1 EP 2391420A1 EP 10701028 A EP10701028 A EP 10701028A EP 10701028 A EP10701028 A EP 10701028A EP 2391420 A1 EP2391420 A1 EP 2391420A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pulse
- pulses
- infrared
- seconds
- massage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000004089 microcirculation Effects 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 31
- 210000004369 blood Anatomy 0.000 title claims abstract description 30
- 230000010412 perfusion Effects 0.000 title claims abstract description 10
- 230000005855 radiation Effects 0.000 claims abstract description 36
- 210000002751 lymph Anatomy 0.000 claims abstract description 18
- 230000005672 electromagnetic field Effects 0.000 claims abstract description 17
- 210000001519 tissue Anatomy 0.000 claims description 19
- 230000006835 compression Effects 0.000 claims description 14
- 238000007906 compression Methods 0.000 claims description 14
- 230000004907 flux Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 230000003692 lymphatic flow Effects 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 230000001960 triggered effect Effects 0.000 claims description 8
- 210000000601 blood cell Anatomy 0.000 claims description 6
- 230000000630 rising effect Effects 0.000 claims description 6
- 238000002329 infrared spectrum Methods 0.000 claims description 4
- 210000005245 right atrium Anatomy 0.000 claims description 4
- 230000000712 assembly Effects 0.000 claims 1
- 238000000429 assembly Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 abstract description 3
- 230000000737 periodic effect Effects 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000001360 synchronised effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 32
- 238000005259 measurement Methods 0.000 description 10
- 210000004088 microvessel Anatomy 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 230000001926 lymphatic effect Effects 0.000 description 7
- 210000000689 upper leg Anatomy 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 210000002565 arteriole Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000000585 Mann–Whitney U test Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004941 influx Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000008844 regulatory mechanism Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000000264 venule Anatomy 0.000 description 2
- 102100040428 Chitobiosyldiphosphodolichol beta-mannosyltransferase Human genes 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000001077 lymphatic endothelium Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000005293 physical law Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000001055 reflectance spectroscopy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000000283 vasomotion Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H9/00—Pneumatic or hydraulic massage
- A61H9/005—Pneumatic massage
- A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/01—Constructive details
- A61H2201/0119—Support for the device
- A61H2201/0138—Support for the device incorporated in furniture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2203/00—Additional characteristics concerning the patient
- A61H2203/04—Position of the patient
- A61H2203/0443—Position of the patient substantially horizontal
- A61H2203/0456—Supine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2203/00—Additional characteristics concerning the patient
- A61H2203/04—Position of the patient
- A61H2203/0443—Position of the patient substantially horizontal
- A61H2203/0468—Prone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
Definitions
- the invention relates to a device for Perfusionsmoduiation in the microcirculation of the blood.
- WO 2008/025731 describes a device for generating a pulsed electromagnetic field with periodic pulses with rising and falling envelopes as a function of certain measurement data of the microcirculation of the blood.
- the object of the invention is to provide a device which is suitable for significantly increasing the microcirculation of the blood.
- a device for perfusion modulation in the microcirculation of the blood consists of a first device for generating a pulsating electromagnetic field, comprising at least one pulse generator and a magnetic coil, with a pulse train of at least two simultaneous or time-shifted pulse groups, wherein for the first pulse group, the pulse time 0 , 1 to 0.2 seconds is at a magnetic flux density of 35 to 100 ⁇ T, and for the second pulse group, the pulse time is 10 to 30 seconds at a magnetic flux density of 2 to 40 ⁇ T; a second device for conveying the lymph stream, are triggered by the massage impulses via a massage device, wherein the massage arrangement comprises a plurality of superimposed circles of horizontally juxtaposed compression chambers in which via a pulse generator and one or more connected thereto pump gradient-shaped pressure pulses for the Compression chambers in one half of the circle and gradient-shaped falling pressure pulses for the chambers in the other half of the circle are to be triggered; a third device for dispensing Infrared radiation emitting
- the functional state of an organ is essentially determined by the functional state of its microcirculation. It is generally accepted today that most functional disorders or diseased states of the organs are determined by microcirculatory disturbances, if not even triggered, at least in their course. Microcirculatory disorders often arise in the wake of macrocirculatory disorders and can gradually develop their own dynamics, which, regardless of macrocirculatory events, significantly influence or even dominate the course of the disease. Without corresponding involvement of the microcirculation, i. the transport processes in the area of
- Microvessels no functional enhancements, healing or restitution processes in the organs are possible. If at all, restrictive microcirculation can, at best, temporarily, to a small extent, affect interference or disease symptoms. The influence of microcirculation is therefore of particular importance.
- the first device for generating a pulsating electromagnetic field consists of at least one pulse generator and at least one coil connected thereto.
- the coil is advantageously a sheet-like structure, preferably a mat, for generating the electromagnetic field.
- This assembly comprises a plurality of circular or rectangular coils arranged side by side or partially overlapping, through which the electromagnetic pulses or pulse groups are transmitted to a user's skin surface which is in close contact therewith.
- the coil may also be placed in an intensive hand applicator, thus occupying a relatively small area of 20-150 cm 2 , to allow for localized applications.
- "simultaneous pulse group” means a passing base signal of the second pulse group of, for example, 2 to 40 ⁇ T and a higher additional signal of 35 to 100 ⁇ T of the first pulse group superposed at intervals of 10 to 30 seconds, preferably 10 to 20 seconds the pulse time of the additional signal is only 0, 1 to 0.2 seconds
- the additional signal is in any case at least 10 ⁇ T and at most 90 ⁇ T above the base signal.
- Time-shifted pulse group 1 means a base signal of the second pulse group aborted after 10 to 30 seconds, an additional signal of 0.1 - 0.2 seconds of the first pulse group immediately following an immediate renewed basic signal, and then a renewed additional signal and repetitions of this sequences.
- the pulse train of the first device consists of pulse groups, which are assigned a pulse time and a magnetic flux density.
- the pulse rate of a first pulse group is preferably 0.1 to 0.2 seconds at a magnetic flux density of 40 to 90 ⁇ T.
- This first pulse group preferably occurs alternately with a second pulse group.
- the pulse time of the second pulse group is preferably 10 to 20 seconds, in particular 15 to 20 seconds.
- the magnetic flux density of the second pulse group is preferably 5 to 34 ⁇ T.
- the first pulse group occurs two to six times per minute, in particular two to four times, particularly preferably two to three times.
- the pulse sequences consist of individual pulses whose amplitudes follow, for example, an exponential function.
- the individual pulses then have a profile approximately as in FIG 995463 B1.
- the individual impulses can also have non-exponential curves, in that they represent rising and falling curve curves with harmonic or anharmonic oscillation sequence, as in WO 2008/025731.
- Aitemierende pulse groups with such waveforms are shown for example in Fig. 4c to 4f in WO 2008/025731. Pulse- Groups with single-cell pulses whose amplitude corresponds to an e-function are preferred for the present invention.
- a particularly preferred embodiment of the invention is when the second pulse group with about 9 - 22 ⁇ T over a period of about 15 to 25 seconds occurs and alternately soificatimpuise for 0.1 - 0.2 seconds of a Impuisrios of 30 -. 45 ⁇ T occur and this alternating sequence is delivered for a total period of 4 to 20 minutes from the first device.
- the pulses are delivered via a pulse generator with connected Spulena ⁇ owski in the form of a mat and are controlled by the control unit.
- the person to be treated lies on the mat with a small distance of 5 - 20 mm to the coil arrangements.
- the pulses of the second pulse group may be two to three times and thus at 6 - 70 ⁇ T, in particular 30 - 68 ⁇ T during the additional pulses of the first pulse group are 60-95 ⁇ T, in particular 80-95 ⁇ T, and the latter are at least 10 ⁇ T difference over that of the second impuis group.
- the coil arrangement may be realized in such a way that one or more flat
- Coils which may be circular or rectangular, are distributed in a planar element, such as a mat next to each other or partially overlapping. Such a mat or cuff is then brought into contact with a part of the human body.
- the coil arrangement can also be designed as a small-area manual or intensive applicator, which is guided over the skin surface.
- the frequency is preferably in the range of 8-40 Hz.
- the second device relates to the transport of the lymph stream.
- the microcirculation is closely linked to the initial lymphatic flow with its transcapillary fluid exchange in the capillary flow area.
- lymphatic flow is a "one-way street.”
- a preferred second device of the invention is therefore in massage arrangements within a body-fitted cuff, e.g. for one leg.
- the massage arrangements are e.g. individual compression chambers, which are arranged horizontally next to each other and vertically (from bottom to top) one above the other in circular planes.
- the chambers are connected in series and are operated by compressed air or a liquid pressure system.
- the adjacent chambers form a circle, eg a circle of 7 chambers.
- the pressure can be increased by means of a pulse generator and one or more connected pumps from chamber 1 to chamber 7, or it can be built in one half of the circle from chamber 1 to chamber 4 (overrun phase) and from chamber 5 to 7 again be degraded (relaxation phase), ie the chambers are controlled one after the other with different pressures via a control unit.
- This first circle is at the end of the cuff at the ankle.
- the next circle above in the direction of the knee / thigh again has several chambers next to each other. Further circles in the cuff follow eg to the end of the thigh.
- the pressure is applied successively from the first circle to the last circle from distal to proximal and always within the circle with gradient-shaped pushing and Entspa ⁇ ungsphase, the pressure for each
- Massage circle can be individually controlled stronger or weaker, as a rule, the pressure in the massage circles is successively increased from one circle level to the next from distal to proximal.
- each circuit is assigned a pump.
- the same pumps can then take over the action phase in the next circle.
- it can also be provided for each chamber, a special pump and then controlled by the pulse generator.
- the function of the second device for the conveyance of lymphatic flow takes place over a period of 5 to 20 minutes.
- the force exerted via the pressure chambers generally corresponds to the force that is also used in manual lymphatic drainage.
- the force is in the range of 2 to 65 N, based on the skin surface.
- the force is in the pressure chambers, which come into contact with the lower extremities, at 2 to 35 N in the relaxation phase and 10 to 65 N in the overrun phase.
- the force is preferably 2 to 20 N in the relaxation phase and 5 to 35 N in the shear phase. This is based on a skin area of about 18 x 18 cm each.
- the chambers are to be designed according to the force absorption.
- the clock for the pressure build-up achieved by pumping is adapted to the rate of vasomotion. Therefore, 2-4 push / relax phases are performed per minute.
- the control of the pressures in the form of thrust and relaxation phase in the sequence of chambers within a circular level and the design of different pressures (strength) in the upper and lower extremities is a completely new principle of action and is a manual lymph drainage and so far on the market clearly superior to equipment for intermittent compression (AIK).
- the invention therefore also relates to a Massagevorrichtu ⁇ g for the transport of the lymph stream, which is characterized in that in a flat structure massage arrangements, for example, 21; 22; 23; 24 horizontally next to each other and vertika!
- a pulse generator and a pump control device 35 are arranged one above the other in several circular planes, in which via a pulse generator and a pump control device 35 a plurality of pumps connected thereto, for example 31; 33 gradient-shaped rising pressure pulses for the chambers 21; 23 in one half of the circle and over the pumps for example 32; 34 gradient-shaped falling pressure pulses for the chambers 22; 24 in the other half of the circle are triggered.
- the function of the second device as well as the first and third takes place
- the evaluation of the stimulation of the (initial) lymph stream is carried out by recognized criteria for characterizing the microcirculation of the blood such as number of blood cell perfu ⁇ d striv nodes in the defined microvessel network (nNP), changes in venular flow ( ⁇ Qven), venolen learnede oxygen exhaustion (ApO 2 ) and about the flow of the initial lymph ( ⁇ QL).
- recognized criteria for characterizing the microcirculation of the blood such as number of blood cell perfu ⁇ d striving nodes in the defined microvessel network (nNP), changes in venular flow ( ⁇ Qven), venolen learnede oxygen exhaustion (ApO 2 ) and about the flow of the initial lymph ( ⁇ QL).
- the absolute difference in oxygen saturation of hemoglobin in the afferent arterioles and efferent venules of the network of a selected tissue target is determined.
- the target is tissue sections of the skin or intestine, which have the targeted blood vessel networks of the organism and are further among the immunologically active organs, and which are further easily accessible for non-invasive measurements selected.
- nNP The number of blood cell-perfused nodal points in the defined microvascular network, nNP, is the number of blood cell-perfused branching sites in this network used as a measure of the distribution state of the blood.
- the venular flow flow Qven and the arteriolar flow flow Qart is the particle flow (blood cell flow) in defined venules or arterioles. It is stated in ⁇ m 3 / s. In a lymphatic drainage according to the invention over 15 minutes, for example, there is an increase in nNP of 15% after about 20 minutes, which then slowly drops again. ApO 2 and ⁇ Qven increase to about 10% in 10 minutes and then decrease again.
- the percent increase with the first device alone is about 1%, with the second device alone about 15% and with both about 22%.
- the percent increase with only the first device is about 5%, with the second device alone about 10% and with both about 18%.
- the percent increase with the first device alone is about 2.5%, with the second device being about 11% and with both about 20%.
- the percentage increase with the first device alone is about 9%, with the second device alone about 10% and with both about 31%.
- the third device in the context of the device according to the invention relates to a device for emitting infrared radiation.
- Thermal radiation in the narrower sense refers to that part of the spectrum of electromagnetic waves that is outside the range of visible light in the longer-wave infrared. Electromagnetic waves with wavelengths ⁇ > 780 Na ⁇ ometer are referred to as infrared rays. The essence of the emission of thermal radiation is a conversion of thermal energy into radiant energy.
- the wavelengths of the temperature radiation of a solid form a continuous spectrum (eg solar spectrum). The focus of radiation is on low temperatures in the range of long wavelengths (infrared), at higher temperatures in the range of shorter wavelengths.
- infrared A wavelength 800-1400 nm, penetration depth into the skin up to 6 mm
- Infrared B wavelength 1400 - 3000 ⁇ m, penetration into the skin up to 2 mm
- Infrared C wavelength 3000 - 10 000 nm, penetration into the skin up to 1 mm.
- absorption in which some of the incident radiation enters the tissue and is absorbed
- Reflection in which a part of the incident radiation is reflected from the surface in accordance with the law of reflection.
- reaction rate temperature rule For the course of biochemical reactions, a relationship between temperature and metabolic activity has long been known as the "reaction rate temperature rule, RGT rule.” Thereafter, the rate of biochemical reactions increases (Intensity of metabolism) at a temperature increase of 10 D C to 2 to 3 times. In detail, however, the manifold networked metabolic processes in heat supply are not yet sufficiently researched.
- Red blood cell desaggregation as a result of increased flow rates Improves blood flow properties in dermal tissue for more favorable microhemodynamic conditions for an unimpeded first immune response (influx and distribution of white blood cells in the skin microvascular networks, rolling phenomena and adhesions on the skin)
- a suitable third device for emitting infrared radiation is one which emits heat pulses whose spectrum corresponds to that of natural sunlight after passing through the air envelope of the earth. This infrared spectrum consists of about 80% infrared A 1 19% infrared B and about 1% infrared C. Industrial area radiators with only about 5% proportion of infrared A are not suitable.
- a third device whose spectrum consists essentially of 90% infrared A, 9% infrared B and 1% infrared C, in particular 100% infrared A.
- a preferred wavelength is 940 nm.
- the energy input into the skin tissue must be homogeneous, in order to avoid unwanted mutual influences of the closely networked microvessels in the skin tissue and thus local "irritation" of the warm receptors in the skin.
- the operation of the third apparatus is therefore greatly influenced by the ambient conditions, especially from site temperature aiigemei ⁇ in the range of 18 - 25 should be C ⁇ to generate a comfortable temperature for the patient.
- a stimulation of the microcirculation by an increased venular effluent with simultaneous extended distribution of the blood in the capillary networks can only be achieved if the interaction of local and nervous controls of the skin circulation can be physiologically favorably influenced.
- the third device it is necessary for the third device to emit a heat radiation pulse at a distance of 0.15-0.40 m from the irradiated skin tissue, which irradiates an increase in the mean temperature of the radiation at a radiation duration of 10 to 30 minutes
- Skin field reaches 2 to 5 0 C. This can be done with a hand-held applicator with a
- Radiating surface of 50 x 50 mm which is filled with about 40 infrared A diodes and achieves a radiated power of 0.6 W.
- a surface applicator with a radiation area of 109 ⁇ 270 mm, which is filled with infrared A diodes at approximately the same density as the hand applicator, and which achieves a radiated power of 5.3 W .
- Several surface applicators can be combined with each other. In order to achieve a homogeneous energy input to the skin tissue, the distances to the skin surface must be observed in accordance with the radiation set. Since the energy per area decreases with the square of the distance from the radiation source, inhomogeneous fields can form on skin surfaces with small radii of curvature.
- a semicircular curved realization of the third device with a length which corresponds approximately to the length of a human body (100 - 200 cm).
- Another embodiment relates to plate-shaped third devices, in which a
- Plate is arranged horizontally and e.g. two plates are arranged on the left and right of the horizontal plate at an angle of 30-60 ° inclined to the tissue surface to be irradiated.
- 120-200 diodes may be arranged per panel (luminescent area), preferably 150-170 diodes, such that the three pivotable panels have a total of preferably 450-510 diodes.
- the modulation of the heat pulse in the form of the luminance in candela (cd) is preferably carried out with a digitally processed signal of the first device for generating a pulsating electromagnetic field and thus according to the pulse sequences as in this first device.
- a digitally processed signal of the first device for generating a pulsating electromagnetic field and thus according to the pulse sequences as in this first device.
- the percent increase with only the first device is about 7% for another subject group, about 14% for the third device alone, and about 25% for both.
- the percent increase with the first device alone is about 5%, with the third device alone about 13% and with both about 22%.
- the percent increase with only the first device is about 5%, with the third device alone about 12% and with both about 28%.
- ApO 2 is about 28% for a combination of the first and third devices as stated above.
- the second device alone results in about 3% improvement. All three devices together give about 37% for ⁇ pO 2
- the tests particularly those made with a combination of the first and second devices and the first, second and third devices, show that macrocirculatory changes are also achievable due to a physiologically favorable influence of the venous return flow in the right atrium clues.
- the pressure difference between the right atrium and the vena cava is about 5% for the combination in a panel of volunteers, while the individual devices in total remain below 4%.
- the flat structure is preferably a leg cuff with compression chambers as massage arrangements. Further advantageous embodiments are described in the above-mentioned second device.
- FIG. 1 Schematic representation of the applications of the device on
- FIG. 2 Schematic representation of a device for conveying the lymph stream in cuff form
- FIG. 3 Presentation of the pressure in the massage circle
- Fig. 4b device for infrared radiation (plates)
- Fig. 5 Diagram showing venous side acid release from apO 2 after treatment with first and second device.
- Fig. 6 Diagram for changing the flow flow of the initial lymph ⁇ Q L after
- FIG. 7 Diagram for venous side oxygen utilization ApO 3 after treatment with first and third device.
- Fig. 8 Diagram for venous side oxygen utilization ApO 2 after treatment with first, second and third device
- FIG. 1 the individual devices in the device for perfusion modulation of the microcirculation of the blood are shown schematically.
- the device for generating a pulsating electromagnetic field is shown as a mat 1.
- one or more coils are arranged, which are connected to a pulse generator (not shown).
- Reference numeral 2 indicates the range for the action of the lymph flow transport device.
- the device itself is e.g. realized in the form of a Bei ⁇ manschette, which can reach to the hip of the patient.
- Also indicated by reference numeral 3 is an area, namely the area for the action of the device for emitting infrared radiation.
- the device itself is e.g. realized according to Fig. 4a or Fig. 4b.
- the three devices are coordinated via a control unit 4 which controls different combinations of the devices with each other and optionally the pulses emitted by each device to the body surface of a patient.
- FIG. 2 shows the second device for conveying the lymph stream in the form of a collagen.
- Several horizontal juxtaposed massage arrangements in the form of chambers are controlled by a pump control unit 35 of the pumps 31 and 32 to successively with different pressures (on and off according to the intended clock sequence descending). Thereafter, the further proximal chambers 23 and 24 (and the other chambers in this county level) are acted upon by rising and falling pressures, so that there is a push phase and a relaxation phase in the circular plane.
- the total pressure increases from distal to proximal, i. each circle level starts with a slightly higher pressure than the previous circle level.
- Fig. 3 the course of the pressure in a massage circle is shown schematically.
- the massage arrangement here consists of 16 chambers in which the massage pressure is increased in the left half of the circle with the chambers 1 to 8 and in the chambers of the right half of the circle corresponding to the shortened arrows in the chambers 9 to 16, the massage pressure is designed slowly sloping.
- the leg cuff according to the invention encloses the lower extremities and can be controlled in these two parts with different forces, as stated above.
- Test 1 Use of the first device (BEMER 3000 plus, manufactured by Innomed AG, Liechtenstein) with pulse groups of 12 ⁇ T for 20 seconds alternately with pulse groups of 35 ⁇ T for 0.12 seconds on a body-sized mat on which the subjects were lying prone. Test time 10 minutes; Frequency 33 Hz.
- Test 2 Use of the second device as two leg cuffs, each with 5 massage circles arranged one above the other. Each circle contains 7 - 9 chambers. Control of pressure pulses (air) in 3 phases per minute. The on the Skin surface force is 2 - 35 N in the relaxation phase and 10 - 65 N in the shear phase; Test time 15 minutes.
- Test 3 use of both devices immediately one after the other with 0.5 min break between them.
- microcirculation values are measured on the subcutis (thigh, flexor side) at intervals of 10 minutes for an observation time of 120 minutes.
- Additional pulse of the first pulse group 0.15 seconds at 45 ⁇ T.
- Example 3 Basic pulse of the second pulse group at 33 ⁇ T for 18 seconds;
- Fig. 4a shows a preferred variant of the third device for emitting infrared radiation.
- the device may be formed as a semicircle or as a smaller pitch circle be.
- the inside of the semicircle is fitted with a series of infrared A-diodes, which allow for an overall increase in skin temperature of up to 8 D C at an average distance of 20 cm from the body surface of a subject.
- Test 1 Use of the first device (BEMER 3000 plus, manufactured by Innomed AG, Liechtenstein) with pulse groups of 12 ⁇ T for 20 seconds alternating with pulse groups of 44 ⁇ T for 0.12 seconds on a body-sized mat on which the subjects were lying prone Test time 10 minutes, frequency 33 Hz.
- Test 2 Use of the third device with predominantly infrared A radiation for a period of 10 minutes on the thigh (flexor side) while lying in prone position.
- Test 3 Use of both devices simultaneously.
- microcirculation values are measured on the subcutis (thigh, flexor side) at 5 minute intervals.
- Example 5 In a manner similar to Example 4, Test 1 was carried out with the following changes: Example 5
- Test 1 Use of the first device (device BEMER 3000 plus, manufacturer Innomed AG, Liechtenstein) with pulse groups of 12 ⁇ T for 20 seconds alternating with
- Test 2 Use of the third device with predominantly infrared A radiation for a period of 10 minutes on the thigh (flexor side) while lying in
- Test 3 Use of both devices simultaneously.
- Test 4 Use of the second device as two Beinmanschette ⁇ each with 5 superposed massage circles. Each circle contains 7 - 9 chambers. Control of pressure pulses (air) in 3 phases per minute. The force acting on the skin surface is 2 - 35 N in the relaxation phase and 10 - 65 N in the shear phase; Test time 15 minutes.
- Test 5 Use of the first and third devices simultaneously and the second
- microcirculation values are measured on the subcutis (thigh, flexor side) at intervals of 5 minutes.
- Example 8 The procedure was as in Example 7, whereby all three devices gave impulses simultaneously in test 5. ⁇ pO 2 was about 40%.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rehabilitation Therapy (AREA)
- Physical Education & Sports Medicine (AREA)
- Pathology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Radiation-Therapy Devices (AREA)
- Massaging Devices (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
L'invention concerne un système pour moduler une perfusion dans la microcirculation sanguine. Ce système comprend un premier dispositif conçu pour générer un champ électromagnétique pulsé comportant une série d'impulsions spécifiques synchrones ou asynchrones d'un champ électromagnétique périodique, qui comprend un premier groupe d'impulsions d'une durée d'impulsion comprise entre 0,1 et 0,2 secondes pour 35-100 µT et un deuxième groupe d'impulsions d'une durée d'impulsion comprise entre 10 et 20 secondes pour 2-40 µT, un deuxième dispositif conçu pour stimuler la circulation lymphatique et qui sert à créer des impulsions de massage par des pressions d'intensité croissante et décroissante, par l'intermédiaire de plusieurs dispositifs de massage juxtaposés, ainsi qu'un troisième dispositif destiné à appliquer un rayonnement infrarouge et qui émet au moins une impulsion thermique, et une unité de commande conçue pour commander les impulsions des trois dispositifs de manière que deux ou trois dispositifs émettent des impulsions simultanément. Le système selon l'invention permet d'améliorer de manière significative des paramètres de la microcirculation et de la macrocirculation sanguines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10701028A EP2391420A1 (fr) | 2009-01-29 | 2010-01-26 | Système pour moduler une perfusion dans la microcirculation sanguine |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09151615 | 2009-01-29 | ||
EP10701028A EP2391420A1 (fr) | 2009-01-29 | 2010-01-26 | Système pour moduler une perfusion dans la microcirculation sanguine |
PCT/EP2010/050852 WO2010086301A1 (fr) | 2009-01-29 | 2010-01-26 | Système pour moduler une perfusion dans la microcirculation sanguine |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2391420A1 true EP2391420A1 (fr) | 2011-12-07 |
Family
ID=40668253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10701028A Ceased EP2391420A1 (fr) | 2009-01-29 | 2010-01-26 | Système pour moduler une perfusion dans la microcirculation sanguine |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110313235A1 (fr) |
EP (1) | EP2391420A1 (fr) |
JP (1) | JP2012516170A (fr) |
KR (1) | KR20110110820A (fr) |
CN (1) | CN102438699A (fr) |
AU (1) | AU2010209776A1 (fr) |
BR (1) | BRPI1007512A2 (fr) |
CA (1) | CA2750468A1 (fr) |
WO (1) | WO2010086301A1 (fr) |
ZA (1) | ZA201104908B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013017586A1 (de) | 2013-10-17 | 2015-05-07 | Turbolite Vertriebs Gmbh | BEHANDLUNGSGERÄT für magnetfeldunterstützte BESTRAHLUNGSTHERAPIEN |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11794040B2 (en) | 2010-01-19 | 2023-10-24 | The Board Of Regents Of The University Of Texas System | Apparatuses and systems for generating high-frequency shockwaves, and methods of use |
JP5752436B2 (ja) * | 2011-02-21 | 2015-07-22 | ファミリー・サービス・エイコー株式会社 | 磁気治療器 |
AR087170A1 (es) | 2011-07-15 | 2014-02-26 | Univ Texas | Aparato para generar ondas de choque terapeuticas y sus aplicaciones |
CA2965866A1 (fr) * | 2013-12-05 | 2015-06-11 | Veriskin, Inc. | Dispositif de surveillance d'une perfusion cutanee |
JP6383945B2 (ja) | 2014-11-11 | 2018-09-05 | 株式会社テクノリンク | 生体刺激装置 |
WO2016187136A1 (fr) * | 2015-05-15 | 2016-11-24 | Veriskin, Inc. | Dispositif de surveillance de flux sanguin cutané |
TWI742110B (zh) | 2016-07-21 | 2021-10-11 | 美商席利通公司 | 具備改良電極壽命之快速脈波電動液壓脈衝產生裝置及使用該裝置生成壓縮聲波之方法 |
KR102587035B1 (ko) | 2017-02-19 | 2023-10-10 | 솔리톤, 인코포레이티드 | 생물학적 매체 내의 선택적 레이저 유도 광학 파괴 |
DE202018002413U1 (de) * | 2018-05-17 | 2018-08-23 | Booster Germany GmbH i. Gr. | Therapie-Gerät mit kurzwelligen Infrarot und pulsierenden Magentfeldern |
US11020603B2 (en) | 2019-05-06 | 2021-06-01 | Kamran Ansari | Systems and methods of modulating electrical impulses in an animal brain using arrays of planar coils configured to generate pulsed electromagnetic fields and integrated into clothing |
AU2020267399A1 (en) | 2019-05-06 | 2021-12-02 | Kamran Ansari | Therapeutic arrays of planar coils configured to generate pulsed electromagnetic fields and integrated into clothing |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8532628U1 (de) * | 1985-11-19 | 1986-04-17 | Elec Elektronische Bauteile und Geräte GmbH, 6209 Heidenrod | Kombiniertes Magnetfeld-Infrarot-Behandlungsgerät |
US5282467A (en) * | 1992-08-13 | 1994-02-01 | Duke University | Non-invasive method for detecting deep venous thrombosis in the human body |
DE4431661A1 (de) * | 1994-09-06 | 1996-03-07 | Kaufmann Walter | Magnetfeldunterbett mit Vibrationsmassage und Entstörung |
US5788647A (en) * | 1997-01-24 | 1998-08-04 | Eggers; Philip E. | Method, system and apparatus for evaluating hemodynamic parameters |
DE29703132U1 (de) * | 1997-02-21 | 1997-08-07 | Schipke, Ulf, 93133 Burglengenfeld | Vorrichtung |
EP0995463B1 (fr) | 1998-10-21 | 2001-08-16 | Wolf. A. Prof. Kafka | Appareil appliquant des signaux électriques ou électromagnétiques pour influencer des processus biologiques |
DE10149418A1 (de) * | 2001-10-02 | 2003-04-17 | Norbert Egger | Fitnessgerät |
US8303511B2 (en) * | 2002-09-26 | 2012-11-06 | Pacesetter, Inc. | Implantable pressure transducer system optimized for reduced thrombosis effect |
DE202004002685U1 (de) * | 2004-02-20 | 2004-05-06 | Hörnstein, Karin | Multifunktionales medizinisches elektrotechnisches Gerät |
DE102006041365B4 (de) * | 2006-08-28 | 2010-09-02 | Peter Gleim | Vorrichtung zur Erzeugung eines pulsierenden elektromagnetischen Feldes mit Impulssteuerung |
US8147395B2 (en) * | 2006-11-28 | 2012-04-03 | Gregory S. Anderson | Bone-activity stimulation apparatus and method |
DE202006019324U1 (de) * | 2006-12-22 | 2007-03-08 | Biro, Stephan | Vorrichtung zur therapeutischen und/oder kosmetischen Behandlung einer Körperzone |
-
2010
- 2010-01-26 KR KR1020117019774A patent/KR20110110820A/ko not_active Application Discontinuation
- 2010-01-26 AU AU2010209776A patent/AU2010209776A1/en not_active Abandoned
- 2010-01-26 EP EP10701028A patent/EP2391420A1/fr not_active Ceased
- 2010-01-26 JP JP2011546817A patent/JP2012516170A/ja active Pending
- 2010-01-26 CN CN2010800064287A patent/CN102438699A/zh active Pending
- 2010-01-26 BR BRPI1007512A patent/BRPI1007512A2/pt not_active Application Discontinuation
- 2010-01-26 US US13/145,963 patent/US20110313235A1/en not_active Abandoned
- 2010-01-26 CA CA2750468A patent/CA2750468A1/fr not_active Abandoned
- 2010-01-26 WO PCT/EP2010/050852 patent/WO2010086301A1/fr active Application Filing
-
2011
- 2011-07-04 ZA ZA2011/04908A patent/ZA201104908B/en unknown
Non-Patent Citations (1)
Title |
---|
See references of WO2010086301A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013017586A1 (de) | 2013-10-17 | 2015-05-07 | Turbolite Vertriebs Gmbh | BEHANDLUNGSGERÄT für magnetfeldunterstützte BESTRAHLUNGSTHERAPIEN |
Also Published As
Publication number | Publication date |
---|---|
KR20110110820A (ko) | 2011-10-07 |
CA2750468A1 (fr) | 2010-08-05 |
ZA201104908B (en) | 2012-03-28 |
US20110313235A1 (en) | 2011-12-22 |
BRPI1007512A2 (pt) | 2016-02-23 |
JP2012516170A (ja) | 2012-07-19 |
WO2010086301A1 (fr) | 2010-08-05 |
AU2010209776A1 (en) | 2011-07-28 |
CN102438699A (zh) | 2012-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2391420A1 (fr) | Système pour moduler une perfusion dans la microcirculation sanguine | |
EP3513836B1 (fr) | Applicateur de champ magnétique à une allure de signal des courants de bobine utilisés en forme de rampe | |
DE69434666T2 (de) | Vorrichtung zur elektrischen nervenstimulation | |
DE60111388T2 (de) | Vorrichtung zur behandlung von vaskulären und orthopädischen krankheiten mittels abgabe von elektrischen impulsen auf die haut zur modulierung des neurovegetativen systems | |
DE102012005030B4 (de) | Vorrichtung und Verfahren zur Stimulation mit Thermoreizen | |
EP2470265B1 (fr) | Dispositif de stimulation de mécanismes autorégulateurs locaux et supérieurs de l'homéostasie de l'organisme | |
DE69924494T2 (de) | Verfahren und vorrichtung zum stimulieren des immunsystems und zum generieren des heilprozesses auf zellenniveau | |
EP2676700A2 (fr) | Procédé et dispositif pour la rééducation du plancher pelvien assistée par une machine | |
DE69227814T2 (de) | Vorrichtung zur Regelung und Verbesserung des Entwicklungs- und Lebenserhaltungszustands lebender Organismen | |
EP2470266B1 (fr) | Dispositif de stimulation de mécanismes autorégulateurs de l'homéostasie de l'organisme | |
EP3946576A1 (fr) | Dispositif de luminothérapie de biostimulation | |
DE1239089B (de) | Verfahren zur Erhoehung der Absorptionsfaehigkeit von Kollagenerzeugnissen im lebenden Koerper | |
DE102006001598A1 (de) | Resorbierbare Akupunkturnadel | |
Skorykh et al. | Using biophysical methods in sheep breading | |
DE102018104515A1 (de) | Vorrichtung zur transkraniellen Magnetstimulation | |
WO2019121622A1 (fr) | Dispositif et procédé pour stimuler la régulation locale de la microcirculation | |
AT510790B1 (de) | Verfahren zur kosmetischen behandlung | |
DE102004024655A1 (de) | Arbeitsverfahren zum Betreiben einer Vorrichtung zur Probanden-Stimulation mittels zeitveränderlicher Mikroströme und/oder Magnetfelder und/oder Licht sowie zugehörige Vorrichtung | |
DE19914979A1 (de) | Vorrichtung und Verfahren zur Reduzierung von Fettgewebe | |
Dae-Kyoo | The Effect of Simultaneous treatment with acupuncture, herb medication and non-invasive laser irradiation of blood vessel on headache | |
DE69821235T2 (de) | Vorrichtung zur ehf punktion (oder therapie mit millimetrischen wellenlängen) | |
Dobšák | Neuro-muscular Electrical Stimulation (NMES) in Rehabilitation of Chronic Diseases | |
DE19904383C2 (de) | Verfahren zum Reizen einer einem Pathologiegebiet zugeordneten Reflexzone sowie Vorrichtung zum Durchführen des Verfahrens | |
DE202018002313U1 (de) | Vorrichtung für die kosmetische Ultraschallbehandlung | |
DE2828097B1 (de) | Moebel zum Entspannen des menschlichen Koerpers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110829 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20121105 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20121223 |